相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1α expression
C. -H. Yeh et al.
BRITISH JOURNAL OF ANAESTHESIA (2011)
In Vitro and In Vivo Evidence for Anti-Inflammatory Properties of 2-Methoxyestradiol
F. H. W. Shand et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Anesthetic Propofol Reduces Endotoxic Inflammation by Inhibiting Reactive Oxygen Species-regulated Akt/IKKβ/NF-κB Signaling
Chung-Hsi Hsing et al.
PLOS ONE (2011)
Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
Amye J. Tevaarwerk et al.
CLINICAL CANCER RESEARCH (2009)
2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats
Stevan P. Tofovic et al.
VASCULAR PHARMACOLOGY (2009)
Central sympatholytics prolong survival in experimental sepsis
Stefan Hofer et al.
CRITICAL CARE (2009)
2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model
S. Huerta-Yepez et al.
CLINICAL IMMUNOLOGY (2008)
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Jordi Rius et al.
NATURE (2008)
The effect of 2-methoxyestradiol, a HIF-1α inhibitor, in global cerebral ischemia in rats
Dachun Zhou et al.
NEUROLOGICAL RESEARCH (2008)
Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice
Donn Spight et al.
SHOCK (2008)
Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1α and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model
Chunhua Chen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cutting edge:: Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis
Carole Peyssonnaux et al.
JOURNAL OF IMMUNOLOGY (2007)
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
Jehana James et al.
INVESTIGATIONAL NEW DRUGS (2007)
2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer
TE Sutherland et al.
CLINICAL CANCER RESEARCH (2005)
2-methoxyestradiol inhibits hypoxia-inducible factor lot, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma
JL Ricker et al.
CLINICAL CANCER RESEARCH (2004)
iNOS-mediated nitric oxide production and its regulation
F Aktan
LIFE SCIENCES (2004)
2-methoxyestradiol alters cell motility, migration, and adhesion
M Sattler et al.
BLOOD (2003)
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
MG Netea et al.
TRENDS IN IMMUNOLOGY (2003)
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
D Chauhan et al.
BLOOD (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Science, medicine, and the future - Pathogenesis of sepsis: new concepts and implications for future treatment
PY Bochud et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
2-Methoxyestradiol interferes with NFκB transcriptional activity in primitive neuroectodermal brain tumors:: implications for management
AP Kumar et al.
CARCINOGENESIS (2003)
2-methoxyestradiol, a promising anticancer agent
NJ Lakhani et al.
PHARMACOTHERAPY (2003)
Mechanism of action of 2-methoxyestradiol: new developments
SL Mooberry
DRUG RESISTANCE UPDATES (2003)
Six at six: Interleukin-6 measured 6 H after the initiation of sepsis predicts mortality over 3 days
DG Remick et al.
SHOCK (2002)
The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors
G Schumacher et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
2-methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate
VS Pribluda et al.
CANCER AND METASTASIS REVIEWS (2000)